Tandem-cycle high-dose melphalan and cisplatin with peripheral blood progenitor cell support in patients with breast cancer and other malignancies-Reference-Cited by-同舟云学术

Tandem-cycle high-dose melphalan and cisplatin with peripheral blood progenitor cell support in patients with breast cancer and other malignancies

Published:2001-05 Issue:5 Volume:7 Page:284-293
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Somlo George,Chow Warren,Hamasaki Victor,Leong Lucille,Margolin Kim,Morgan Robert,Sniecinski Irena,Frankel Paul,Reardon Debbie,Longmate Jeff,Raschko James,Shibata Stephen,O'Donnell Margaret,Smith Eileen,Tetef Merry,Forman Stephen,Yen Yun,Molina Arturo,Doroshow James H

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Autologous Stem Cell Transplantation in Systemic Light Chain Amyloidosis;Clinical Lymphoma Myeloma and Leukemia;2024-07

2. The Expression of ZNF268 and Its Role in The Cisplatin-based Chemoresistance of Breast Cancer;Heliyon;2023-08

3. Long-Term Survival after High-Dose Chemotherapy Followed by Peripheral Stem Cell Rescue for High-Risk, Locally Advanced/Inflammatory, and Metastatic Breast Cancer;Biology of Blood and Marrow Transplantation;2012-08

4. An association between invasive breast cancer and familial idiopathic hyperparathyroidism: a case series and review of the literature;Breast Cancer Research and Treatment;2008-05-26

5. Consolidation with High-Dose Combination Alkylating Agents with Bone Marrow Transplantation Significantly Improves Disease-Free Survival in Hormone-Insensitive Metastatic Breast Cancer in Complete Remission Compared with Intensive Standard-Dose Chemotherapy Alone;Biology of Blood and Marrow Transplantation;2006-02